4//SEC Filing
Betz Stephen F. 4
Accession 0000950170-24-097085
CIK 0001658247other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:30 PM ET
Size
5.1 KB
Accession
0000950170-24-097085
Insider Transaction Report
Form 4
Betz Stephen F.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-08-12$47.68/sh−3,000$143,040→ 72,611 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $47.68 per share. The range of sales prices on the transaction date was $47.60 to $47.80 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001886575
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:30 PM ET
- Size
- 5.1 KB